ATLASCalidi Biotherapeutics (CLDI) earnings date: Nov 12, 2026
Calidi Biotherapeutics (CLDI) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CLDI
| Last price | $0.69 (+2.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.9% |
| Earnings beat history | Beat the EPS estimate in 0 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Calidi Biotherapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Calidi Biotherapeutics reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Calidi Biotherapeutics. You can switch it off at any time.
Alert me before CLDI reportsFree to start. Creating an account takes under a minute.
CLDI earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Jun 17, 2026 · In line |
| Beat rate (last 5 reports) | 0 of 5 (0%) |
| Average EPS surprise | -22.2% |
| Average move around a report | ±5.3% (last 5) |
| Sector | Healthcare · Biotechnology |
Calidi Biotherapeutics earnings history: last 5 reports
Calidi Biotherapeutics last reported on Jun 17, 2026: EPS of $3.16 against an estimate of $3.12 (+1.3% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jun 17, 2026 | $3.12 | $3.16 | +1.3% | In line | +6.3% |
| Nov 13, 2025 | -$26.88 | -$35.36 | -31.6% | Miss | -0.7% |
| Nov 4, 2025 | $3.16 | $3.01 | -4.7% | Miss | -2.0% |
| Aug 8, 2025 | -$21.12 | -$31.89 | -51.0% | Miss | -12.5% |
| May 14, 2025 | -$28.80 | -$35.94 | -24.8% | Miss | -5.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CLDI
See the fair value, the probability range and the earnings history of Calidi Biotherapeutics on its ATLAS page.
Calidi Biotherapeutics (CLDI) stock analysisPlans from €3.99 a month.
Calidi Biotherapeutics earnings: frequently asked questions
When does Calidi Biotherapeutics (CLDI) report earnings?
Calidi Biotherapeutics is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does CLDI beat earnings estimates?
Of its last 5 reports with a recorded result, Calidi Biotherapeutics beat the EPS estimate 0 times; the average surprise was -22.2%. Past results do not predict the next one.
How much does CLDI move around earnings?
Over its last 5 reports the stock moved an average of 5.3% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Calidi Biotherapeutics beat earnings estimates last quarter?
Calidi Biotherapeutics last reported on Jun 17, 2026: EPS of $3.16 against an estimate of $3.12 (+1.3% surprise), in line with the estimate.
How much does CLDI usually move in a day?
On a normal trading day the ATLAS model puts CLDI’s one-day range at about ±4.9%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer